arrow
V

Violet Chihota

University of Witwatersrand
H指数:28
被引数:3,199

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety of short-course weekly rifapentine and isoniazid (3HP) for TB preventive treatment at conception and during first trimester in women living with HIV: a secondary analysis of WHIP3TB trial

HIV感染者孕期及孕早期使用短程每周利福平联合异烟肼(3HP)进行结核病预防治疗的安全性:WHIP3TB试验的二次分析

2026-05-170
OA
Dynamics of QuantiFERON-TB Gold Plus Results in a Large TB Preventive Treatment Trial Across 3 High-Burden HIV/TB Countries

在三个高负担HIV/TB国家的大型结核预防治疗试验中QuantiFERON-TB Gold Plus结果的变化动力学

2026-01-010
PRE
An evaluation of a choice architecture-based intervention on prescribing of TB preventive treatment to people living with HIV in southern Africa (the CAT study): a cluster-randomised trial

基于选择架构的干预措施对南部非洲人类免疫缺陷病毒感染者结核病预防性治疗处方的影响评估(CAT研究):一项集群随机试验

2025-05-240
OA
Simultaneous initiation of dolutegravir-based antiretroviral therapy and once-weekly rifapentine and isoniazid for tuberculosis prevention in antiretroviral-naive people with HIV: an open-label, non-randomised, phase 1/2 trial

同时启动以多替阿巴拉韦为基础的抗逆转录病毒治疗和每周一次利福平肼和异烟肼用于结核病预防在抗逆转录病毒初治的HIV感染者中的研究:一项开放标签、非随机、1/2期临床试验

2025-05-080
PRE
Monocyte Transcriptional Responses to Mycobacterium tuberculosis Associate with Resistance to Tuberculin Skin Test and Interferon Gamma Release Assay Conversion
MSPHERE
IF3.1
2022-06-2917
OAAI
Annual Tuberculosis Preventive Therapy for Persons With HIV Infection A Randomized Trial
2021-10-0121
PRE
Monocyte metabolic transcriptional programs associate with resistance to tuberculin skin test/interferon-γ release assay conversion
2021-07-1517
OA